Evaluation of Surgical Stress Associated with Video-assisted Thoracic Surgery for Esophageal Cancer According to Interleukin-6 Variation in Pleural Cavity Lavage Fluid  by KOHMOTO Masahiro et al.
Showa Univ J Med Sci 28（1）, 63～72, March 2016
Evaluation of Surgical Stress Associated with Video-assisted Thoracic 
Surgery for Esophageal Cancer According to Interleukin-6  
Variation in Pleural Cavity Lavage Fluid
Masahiro KOHMOTO＊, Masahiko MURAKAMI, Koji OTSUKA,  
Satoru GOTO, Tomotake ARIYOSHI, Takeshi YAMASHITA,  
Kentaro MOTEGI, Rei KATO, Akira SAITO, Hiromi DATE,  
Kimiyasu YAMAZAKI, Yuta ENAMI, Makoto WATANABE  
and Takeshi AOKI
Abstract : Esophagectomy for esophageal cancer is one of the most invasive 
gastrointestinal surgeries.  In 1996, we introduced video-assisted thoracic surgery 
for esophageal cancer （VATS-E） to reduce surgical stress.  In 2010, we started 
employing articial pneumothorax （AP） using carbon dioxide gas in VATS-E to 
further reduce surgical stress.  In this study, we evaluated interleukin-6 （IL-6） 
levels in pleural cavity lavage uid （PLF） of patients undergoing VATS-E with or 
without AP, and examined the effect of AP on VATS-E-induced stress.  This non-
randomized study included patients who underwent VATS-E with or without AP 
at Showa University Hospital between 2009 and 2013 and from whom PLF could 
be collected.  IL-6 concentrations in PLF were examined before and after the 
thoracic part of the operation.  We compared IL-6 variation, dened as the differ-
ence between IL-6 concentrations in PLF before and after the thoracic part of the 
operation, between patients for whom AP was used and those for whom it was 
not used.  A total of 52 patients were included in the study ; 26 underwent VATS-
E with AP （group AP）, and 26 underwent VATS-E without AP （group NP）.  IL-6 
concentrations in PLF were significantly elevated immediately after the thoracic 
part of the operation in both groups.  IL-6 variation in PLF correlated with both 
thoracic operative time and blood loss, which were considered practical parameters 
of surgical stress, and was signicantly lower in group AP than in group NP.  In 
conclusion, IL-6 variation in PLF is a useful and sensitive maker of surgical stress 
during VATS-E.  VATS-E with AP is less invasive than VATS-E without AP 
because AP lowers the perioperative systemic inflammatory response to thoracic 
surgery.
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Introduction
　Esophagectomy for esophageal cancer is one of the most invasive gastrointestinal surgeries, and 
is associated with high rates of morbidity and mortality.  Thoracoscopic esophagectomy was rst 
reported in 1992 1）.  In 1996, we introduced video-assisted thoracic surgery for esophageal cancer 
（VATS-E） in the left lateral decubitus position to reduce the extent of surgical stress caused by 
esophagectomy 2, 3）.  We have conducted several studies examining esophageal cancer and VATS-
E 4-7）.  In 2010, we started employing articial pneumothorax （AP） using carbon dioxide gas in 
VATS-E to further reduce surgical stress.
　With regard to surgical stress, interleukin-6 （IL-6） has been shown to play a pivotal role 
in the acute phase response after surgery 8）.  Serum IL-6 levels are elevated after elective 
surgery and are signicantly correlated with the extent and severity of surgical stress 8）.  We 
previously demonstrated that VATS-E, which is less invasive than conventional esophagec-
tomy, results in lower postoperative serum IL-6 concentrations compared with conventional 
esophagectomy 9）.
　In this study, we focused on IL-6 concentrations in pleural cavity lavage uid （PLF） because 
IL-6 concentrations in chest drainage fluid following esophagectomy peak simultaneously with 
serum IL-6 concentrations after surgery 10）.  We evaluated IL-6 concentrations in the PLF of 
patients who underwent VATS-E with or without AP, and thereby examined the effect of AP on 
VATS-E-induced surgical stress.
Materials and methods
Patients
　Patients who underwent VATS-E at Showa University Hospital between 2009 and 2013 and 
from whom PLF could be collected were enrolled in this non-randomized study.  All of them 
had undergone routine presurgical evaluations including blood chemistry ; barium swallow ; esoph-
agogastroduodenoscopy with biopsy ; computed tomography of the neck, chest, and abdomen ; 
electrocardiography ; spirometry ; and echocardiography.  They were all evaluated for tolerance of 
anesthesia and an invasive operation.  We retrospectively evaluated patient preoperative status, 
operative outcomes, and systemic responses to surgery, including serum white blood cell （WBC） 
counts, serum C-reactive protein （CRP） concentrations, and PLF IL-6 concentrations.  We evalu-
ated pathologic characteristics, including tumor invasion, node metastasis, and tumor stage, accord-
ing to the Japanese Classication of Esophageal Cancer criteria 11）.  We dened postoperative 
complications as grade II or higher according to the Clavien–Dindo classication 12）.  The ethics 
board of Showa University approved the study protocol.
Surgical procedure and perioperative management
　VATS-E was performed under general anesthesia and left lung ventilation with a bronchial 
blocker, with or without AP.  AP was created by insufation of carbon dioxide gas into the right 
chest cavity space at 8 mmHg.  All patients were in the left lateral decubitus position and had 
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ve ports introduced into the right pleural cavity.  A radical esophagectomy and a mediastinal 
lymphadenectomy were carried out during the thoracic part of the operation.  An esophageal 
substitute was constructed from the gastric tube by hand-assisted laparoscopy, inserted via the 
retrosternal route, and cervical anastomoses were constructed in all patients.
　There was no change in perioperative management of patients during the study period.  Meth-
ylprednisolone sodium succinate （250 mg） was given to all patients by intravenous immediately 
before the operation.  All patients were given sivelestat, a neutron elastase inhibitor, by intrave-
nous at a dosage of 300 mg per day, beginning 30 min before the operation and continuing until 
postoperative day 2.  All patients were extubated immediately after the operation.
Measurement of IL-6 concentrations in PLF
　The right chest cavity was lavaged with 100 ml normal saline and the lavage uid was col-
lected before and after the thoracic part of the operation.  The lavage pleural effusion was 
separated by cold centrifugation at 1,500×g for 10 min and then stored at -80℃ until analysis. 
IL-6 concentration was measured using a chemiluminescent enzyme immune assay （SRL, Tokyo, 
Japan）.  We defined variation in IL-6 concentrations in PLF as the difference between IL-6 
concentrations in PLF before and after the thoracic part of the operation.
Statistical analysis
　Study data are reported as median （range） values.  Statistical analysis was performed using 
the Wilcoxon test or Chi-square test.  Correlation analysis was performed using Spearman’s rank 
correlation coefficient analysis.  All analyses were performed using JMPⓇ 11 software （SAS 
Institute, Cary, NC, USA）.  Probability values ＜0.05 were considered statistically signicant.
Results
Patient characteristics and surgical outcomes
　A total of 52 patients were included in the study ; 26 underwent VATS-E with AP （group 
AP）, and 26 underwent VATS-E without AP （group NP）.  Patient characteristics are presented 
in Table 1.  There were no signicant differences in sex, age, preoperative respiratory function, 
preoperative therapy, or pathological ndings between the two groups.
　Surgical outcomes are presented in Table 2.  There were no signicant differences in thoracic 
or total operative times, or in the number of thoracic or total dissected lymph nodes between 
the groups.  However, thoracic blood loss and total blood loss were signicantly lower in group 
AP.  The incidence of postoperative pneumonia, anastomotic leakage, and recurrent laryngeal 
nerve paralysis were not signicantly different between the two groups （Table 3）, and all compli-
cations improved with symptomatic treatment.
Perioperative changes in serum WBC counts and serum CRP concentrations
　The perioperative changes in serum WBC counts and serum CRP concentrations are shown 
in Fig. 1.  No signicant differences were observed in serum WBC counts at any time point. 
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However, serum CRP concentrations were signicantly lower on postoperative days 1, 2, and 3 
in group AP.
Changes in IL-6 concentrations in PLF
　The IL-6 concentrations in PLF before and after the thoracic part of the operation in group 
AP and group NP are shown in Table 4.  IL-6 concentrations in PLF increased immediately 
after the thoracic part of the operation in both groups.
Table 1　Patient characteristics
Group AP Group NP
p value
n＝ 26 n＝ 26
Sex （M/F） 24 / 2 24 / 2 1.0000
Age （years） 63.5 （60.5-72.5） 66.5 （59.3-72.0） 0.9561
％VC （％） 111.0 （100.5-120.1） 111.8 （99.9-121.7） 0.9923
FEV1.0％ （％） 71.0 （65.8-76.7） 72.3 （66.8-78.7） 0.7415
Preoperative therapy 0.2715
Neoadjuvant chemotherapy 23 （88.5） 20 （76.9）
Neoadjuvant chemoradiotherapy 0 0
None  3 （11.5）  6 （23.1）
Tumor location 0.4446
Upper  3 （11.6）
Middle 21 （80.8） 17 （65.4）
Lower 2 （7.7）  3 （11.5）
Tumor depth （pT） 0.3657
1a  7 （26.9）  3 （11.5）
1b 13 （50.0） 12 （46.2）
2 2 （7.7）  3 （11.5）
3  4 （15.4）  8 （30.8）
4 0 0
Lymph node metastasis （pN） 0.4967
0 18 （69.2） 15 （57.7）
1  4 （15.4）  4 （15.4）
2  4 （15.4）  5 （19.2）
3 0 2 （7.7）
Tumor progression （pStage） 0.4779
0  6 （23.1）  3 （11.5）
1 11 （42.3）  9 （34.6）
2  6 （23.1）  8 （30.8）
3  3 （11.5）  6 （23.1）
4 0 0
Data are reported as median （range） or number （％）. ％VC, percentage of predicted 
vital capacity ; FEV1.0％, forced expiratory volume in 1 second as a percentage of 
forced vital capacity.
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Table 2　Surgical outcomes
Group AP Group NP
p value
n＝ 26 n＝ 26
Operative time （min）
　Thoracic part 222.5 （178.8—284.0） 237.5 （168.8—282.5） 0.8332
　Total 415.0 （318.8—461.3） 407.5 （318.8—492.5） 0.8332
Blood loss （g）
　Thoracic part  60.0 （20.0—100.0） 182.5 （100.0—250.0） ＜0.001
　Total 147.5 （73.8—285.0） 315.0 （187.5—396.3） 0.0069
Number of dissected lymph nodes
　Thoracic part  32.0 （26.8—40.3）  29.0 （20.3—36.5） 0.2092
　Total  53.0 （40.5—77.0）  56.0 （32.3—96.5） 0.8886
Data are reported as median （range）.
Table 3　Postoperative complications
Group AP Group NP
p value
n＝ 26 n＝ 26
Pneumonia 0 1 （3.9） 0.3126
Anastomotic leakage 0 0 1.0000
RLN paralysis 1 （3.9） 0 0.3126
Data are reported as number （％）
RLN, recurrent laryngeal nerve ; complications are defined as 
grade II or higher according to the Clavien—Dindo classication.
Fig. 1.  Postoperative changes in serum white blood cell （WBC） count and serum C-reactive protein 
（CRP） concentration
＊p＜0.05 ● : Group AP, ○ : Group NP, Pre : preoperative, Post : postoperative, POD : postoperative day.
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Correlation between IL-6 variation in PLF and thoracic operative time and blood loss
　The Spearman’s rank correlation coefcient （RS） analysis, shown in Table 5, revealed signi-
cant correlations between IL-6 variation in PLF and both thoracic operative time （RS＝ 0.43 ; 
p＜ 0.0015） and thoracic blood loss （RS＝ 0.57 ; p＜ 0.0001）.
IL-6 variation in PLF
　The IL-6 variation in PLF for group AP and group NP is shown in Fig. 2.  IL-6 variation in 
PLF was signicantly lower in group AP than in group NP （188.8 pg / ml ［range, 87.7—684.8 pg /
Table 4　 Interleukin-6 concentrations in pleural cavity lavage uid 
before and after the thoracic part of the operation
Before After p value
Group AP 0.7 （0.3-1.7） 193.0 （88.5-685.5） ＜ 0.001
Group NP 0.9 （0.3-5.1） 2425.0 （666.0-4862.5） ＜ 0.001
Data are reported as median （range）.
Table 5　 Correlations between interleukin-6 
variation in pleural cavity lavage 
uid and thoracic operative time and 
thoracic blood loss
RS p value
Thoracic operative time 0.43 0.0015
Thoracic blood loss 0.57 ＜0.001
RS : Spearman’s rank correlation coefcient.
Fig. 2.  Interleukin-6 （IL-6） variation, defined as the 
difference between IL-6 concentrations in 
pleural cavity lavage fluid （PLF） before and 
after the thoracic part of the operation, for 
group AP and group NP＊
＊IL-6 variation in PLF was significantly lower 
in group AP than in group NP （p＜0.001）.
Fig. 3.  Interleukin-6 （IL-6） variation in pleural cavity 
lavage fluid （PLF） per gram of thoracic blood 
loss for group AP and group NP＊
＊IL-6 variation in PLF per gram of thoracic 
blood loss was significantly lower in group AP 
than in group NP （p＝0.0113）.
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ml］ vs 2423.4 pg / ml ［range, 665.7—4861.9 pg / ml］; p＜ 0.001）.  The IL-6 variation in PLF per 
gram of thoracic blood loss for groups AP and NP is shown in Fig. 3 ; this variation was also 
signicantly lower in group AP than in group NP （2.8 pg / ml / g ［range, 1.1—12.7 pg / ml / g］ vs 
10.9 pg / ml / g ［range, 7.0—23.4 pg / ml / g］; p＝ 0.0113）.
Comparison of patients who did and did not have preoperative therapy
　The number of thoracic dissected lymph nodes and IL-6 variation in PLF for patients who 
did or did not have preoperative therapy （neoadjuvant chemotherapy） are shown in Table 6 and 
Fig. 4, respectively.  No signicant differences were found in either of these measures between 
patients who had preoperative therapy and those who did not.
Discussion
　Our data show that IL-6 variation in PLF is a useful indicator of thoracic surgical stress in 
VATS-E, and that VATS-E with AP is less invasive than VATS-E without AP.
Table 6　 Number of dissected lymph nodes for patients who did or did not have neoad-
juvant chemotherapy as preoperative therapy
Preoperative therapy
Yes No p value
n＝ 43 n＝ 9
Number of dissected lymph nodes
Thoracic part 32.0 （24.8—40.1） 30.0 （17.5—32.0） 0.3463
Total 60.0 （41.0—88.0） 44.5 （30.1—54.3） 0.0833
Data are reported as median （range）.
Fig. 4.  Interleukin-6 （IL-6） variation in pleural cavity lavage fluid （PLF） 
for patients who did or did not have neoadjuvant chemotherapy as 
preoperative therapy＊
＊No significant difference was found in IL-6 variation in PLF between 
patients who had preoperative therapy and those who did not.
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　IL-6 is regarded as an important mediator that reflects the extent and severity of surgical 
stress13）.  Operative time and blood loss during surgery are considered practical parameters of 
surgical stress.  Postoperative elevation of serum IL-6 levels, calculated as the difference between 
levels before the operation and 24 hours after the beginning of the operation, is closely cor-
related with operative time and blood loss 8）.  Cytokines such as IL-6 are induced and secreted 
mainly in the operative eld and appear in the bloodstream almost simultaneously during the 
early postoperative course.  IL-6 concentrations in serum and chest drainage uid peak simulta-
neously in the early phase after surgery.  The peak IL-6 concentration after esophagectomy in 
chest drainage uid is 100-fold greater than that in serum 10）.  However, to our knowledge, there 
are no previous reports on IL-6 concentrations in PLF after the thoracic part of VATS-E.
　In this study, we showed that IL-6 concentrations in PLF were signicantly elevated immedi-
ately after the thoracic part of the operation in patients who did have AP and those who did 
not.  In addition, we showed that IL-6 variation in PLF, dened as the difference between IL-6 
concentrations before and after the thoracic part of the operation, were correlated with thoracic 
operative time and blood loss in both patient groups.  These ndings indicate that IL-6 varia-
tion in PLF is a sensitive marker of the invasiveness of VATS-E.  IL-6 variation in PLF was 
signicantly lower in group AP than in group NP.  Thoracic blood loss was signicantly lower 
by about 100 g in group AP, and the signicant differences in IL-6 variation in PLF could be 
caused by IL-6 concentrations in the blood lost during the thoracic part of the operation.  We 
did not directly examine IL-6 concentrations in the blood lost during the thoracic part of the 
operation.  We evaluated IL-6 variation in PLF per gram of thoracic blood loss and found that 
it was also signicantly less in group AP than in group NP.  We propose that IL-6 concentra-
tions in the blood that was lost did not affect IL-6 variation in PLF.  In both groups, there 
were no changes in patient perioperative management and few changes in the VATS-E surgical 
procedures.  The quality of the thoracic part of the operation did not differ in terms of thoracic 
lymph node dissection.  Forty-three of 52 patients underwent neoadjuvant chemotherapy as 
preoperative therapy and nine patients did not undergo preoperative therapy.  No signicant dif-
ferences were found in the number of thoracic dissected lymph nodes and IL-6 variation in PLF 
between those who did and those who did not have preoperative therapy.  We considered that 
the level of difculty of VATS-E did not differ between those who did and those who did not 
have preoperative therapy.  The only change was the insufation of carbon dioxide gas to create 
AP.  These ndings suggest that AP made a large contribution to the decrease in IL-6 variation 
in PLF.
　Serum IL-6 concentrations after thoracic surgery, such as esophagectomy and pneumonectomy, 
are much higher than after abdominal surgery, such as pancreaticoduodenectomy and colorectal 
resection, in spite of similar operative time and blood loss 10）.  These ndings indicate that tho-
racic surgery is more invasive than abdominal surgery.  Lung tissue produces IL-6 after appropri-
ate stimulation 14-16）.  Lung tissue contains an extensive vascular bed, which includes inammatory 
and endothelial cells that facilitate the induction of cytokines due to direct injury, tissue damage, 
and lung compression and decompression caused by surgical procedures 10）.  AP keeps the lungs 
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compressed, maintains pressure on the elevated diaphragm, and facilitates a better view of intra-
thoracic structures in children undergoing thoracoscopic surgery 17）.  We believe that AP provided 
similar benets to the adult patients in our study, since a stronger manual compression of the 
lungs using a paddle was required to achieve the required operative eld in group NP.  In addi-
tion, the right lung was exposed to carbon dioxide gas, delivered by insufation, in group AP, 
but no signicant differences were found in postoperative lung complications between the two 
groups.  These ndings suggest that AP compresses the lung wholly （thereby reducing the need 
for manual lung compression using a paddle）, provides a better operative eld, and suppresses 
the secretion of IL-6 from lung tissue.
　A limitation of this study was that, out of all patients who underwent VATS-E during the 
study period, it included only those from whom PLF could be collected.  Also, we evaluated 
IL-6 concentrations in PLF only.  In the future, we will evaluate more patients and further 
explore the relationship between PLF and serum IL-6 concentrations.
　In conclusion, IL-6 variation in PLF is a useful and sensitive maker of surgical stress dur-
ing the thoracic part of VATS-E.  VATS-E with AP is less invasive than VATS-E without AP. 
Using AP during VATS-E lowers the perioperative systemic inammatory response to thoracic 
surgery, and is therefore benecial to patients.
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